Inflammatory bowel disease - Latest research and news | Nature
Inflammatory bowel disease is a chronic condition of unknown origin characterized by severe inflammation and mucosal destruction in the intestine.
The mysteries of inflammatory bowel disease are being cracked
Aug 16, 2024 · When geneticist James Lee and his colleagues published a paper in June linking a gene to inflammatory bowel disease (IBD), he didn’t expect the public to take much notice. Things did not go as ...
Inflammatory bowel disease articles within - Nature
Oct 24, 2024 · Inflammatory bowel disease (IBD) is an immune-mediated inflammatory disease (IMID). Here, the authors review evidence on the preclinical phase of IBD, outlining and describing the proposed at-risk ...
Inflammatory bowel disease - Nature
Dec 21, 2016 · The symptoms of Crohn's disease and ulcerative colitis, the two main forms of inflammatory bowel disease (IBD), can be severe and lifelong. And the condition is becoming increasingly common worldwide.
Inflammatory bowel disease - Nature
Inflammatory bowel disease (IBD) is a chronic inflammatory disorder of the gastrointestinal tract, including ulcerative colitis, Crohn's disease, and unclassified IBD.
Inflammatory bowel disease - Nature
Dec 21, 2016 · Inflammatory bowel disease (IBD) can be a debilitating condition to live with, yet it is largely invisible to all but the afflicted individual. The condition has two main forms — Crohn's disease ...
Interpreting modern randomized controlled trials of medical …
Oct 8, 2024 · In this Review, Ma and colleagues discuss the evolution in clinical trial designs for inflammatory bowel disease (IBD), their implications for clinical care, and identify future directions for the ...
Inflammatory bowel disease uncovered in fecal immunochemical …
Oct 3, 2024 · Inflammatory Bowel Disease (IBD) is a chronic inflammatory condition that usually affects younger adults but has a second incidence peak in the older population.
Inflammatory bowel disease | Nature Medicine
Aug 19, 2024 · A new study identifies oncostatin M (OSM) as a potential biomarker and therapeutic target for anti-tumor necrosis factor (TNF)-refractory inflammatory bowel disease (IBD), and pinpoints mucosal ...
Disease prevention trials in IBD: feasibility to future outlook
Sep 20, 2024 · Therapeutic advances in inflammatory bowel disease (IBD) have been universally directed towards patients with established disease to control inflammation, ameliorate symptoms and hinder disease ...